• Featured Product
  • KD/KO Validated

PLK1 Polyklonaler Antikörper

PLK1 Polyklonal Antikörper für WB, IF/ICC, FC (Intra), ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IF/ICC, FC (Intra), IP, CoIP, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 10305-1-AP

Synonyme

Polo-like kinase 1, Polo like kinase 1, PLK-1, PLK 1, PLK



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHEK-293-Zellen, A549-Zellen, HeLa-Zellen, Jurkat-Zellen, Maushodengewebe, MDA-MB-453s-Zellen, Rattenhodengewebe, U2OS-Zellen
Erfolgreiche Detektion in IF/ICCU2OS-Zellen
Erfolgreiche Detektion in FC (Intra)Ramos-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:1000-1:8000
Immunfluoreszenz (IF)/ICCIF/ICC : 1:50-1:500
Durchflusszytometrie (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

10305-1-AP bindet in WB, IF/ICC, FC (Intra), IP, CoIP, ELISA PLK1 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen PLK1 fusion protein Ag0284
Vollständiger Name polo-like kinase 1 (Drosophila)
Berechnetes Molekulargewicht 68 kDa
Beobachtetes Molekulargewicht 68 kDa
GenBank-ZugangsnummerBC002369
Gene symbol PLK1
Gene ID (NCBI) 5347
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

PLK1(Polo-like kinase 1), also named as PLK and STPK13, belongs to the protein kinase superfamily, Ser/Thr protein kinase family and CDC5/Polo subfamily. PLK1 is a Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of APC/C inhibitors, and the regulation of mitotic exit and cytokinesis.The localization of Polo changes during the cell cycle. In interphase, Polo shows a mostly diffuse cytoplasmic localization. Polo becomes concentrated on centrosomes from early prophase and appears on centromeres or kinetochores from late prophase, before nuclear envelope breakdown (NEB). After anaphase onset, Polo relocalizes to the central spindle and remains enriched at the midbody ring in late stages of cytokinesis (PMID: 29167465).

Protokolle

Produktspezifische Protokolle
WB protocol for PLK1 antibody 10305-1-APProtokoll herunterladen
IF protocol for PLK1 antibody 10305-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB,IF

J Clin Invest

PLK1 inhibition dampens NLRP3 inflammasome-elicited response in inflammatory disease models

Authors - Marta Baldrighi
humanWB

Adv Sci (Weinh)

Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer

Authors - Huaiyuan Liang
  • KD Validated
human,mouseWB

Sci Adv

Cascade dynamic assembly/disassembly of DNA nanoframework enabling the controlled delivery of CRISPR-Cas9 system

Authors - Nachuan Song
humanWB,IF

Nat Commun

Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.

Authors - Wengui Shi
humanWB

Biomaterials

Biocompatible PEGylated Gold nanorods function As cytokinesis inhibitors to suppress angiogenesis.

Authors - Hongyuan Song
ratWB

Cell Rep

Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex

Authors - Kellen D Winden